Management ChangeApr 28, 2026, 04:52 PM
FENC Director Rostislav Raykov to Retire; Board Size Reduced
AI Summary
Fennec Pharmaceuticals Inc. announced that Rostislav Raykov will retire from its Board of Directors, effective immediately following the 2026 annual meeting of shareholders. His departure is not due to any disagreement with the company. Concurrently, the Board has decided to reduce its size from six to five directors, effective after the Annual Meeting, with no expected vacancies.
Key Highlights
- Rostislav Raykov to retire from Fennec Pharmaceuticals' Board of Directors.
- Mr. Raykov's current term expires immediately following the 2026 annual meeting.
- His departure is not due to any disagreement with the Company.
- Board of Directors size will be reduced from six to five directors.
- The reduction in board size is effective immediately following the Annual Meeting.
Price Impact
More from FENC